glp-1 obesity drugs news today 2025 Didn't take much for the time magazine to do a flip! From “The big promise” to “A metabolic whiplash” A new study came out yesterday that showed that stopping for Swiss Re study: GLP-1 drugs

Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically (2018)

This innovative treatment targets and dissolves stubborn fat deposits that often resist even the most dedicated diet and exercise efforts

iScience 25 (6), 104435

The authors then profiled metabolic changes after treatment with vitamin C

However, regulatory guidance states that when the ratio of the area under the concentration-time curve (AUC) of the victim drug with and without the perpetrator drug falls outside the range of 0.81.25, there is a potential risk of a clinically significant impact, necessitating further investigation